Display options
Share it on

Nan Fang Yi Ke Da Xue Xue Bao. 2017 Sep 20;37(9):1228-1233.

[Protective effect of butylphthalide in a cell model of Alzheimer's disease induced by Aβ25-35 in Neuro 2a cells].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

[Article in Chinese]
Jing-Wen Xie, Yan Zhao, Xia-Lu Feng, Fang-Bo Lin, Jing Luo, Xin Liu, De-Ren Hou

Affiliations

  1. Department of Neurology, Third Xiangya Hospital of Central South University, Changsha 410013, China.E-mail: [email protected].

PMID: 28951367 PMCID: PMC6765483

Abstract

OBJECTIVE: To study the protective effect of butylphthalide in a cell model of Alzheimer's disease(AD) induced by Aβ25-35 in Neuro 2a (N2a) cells.

METHODS: N2a cells were divided into AD group, butylphthalide (NBP) group and control group. AD cell model was established by adding 20 µmol/L Aβ25-35 to cultured N2a cells. The cells in NBP group were treated with 0.1, 1, 10, or 100 µmol/L NBP 4 h prior to treatment with 20 µmol/L Aβ25-35. The cell viability were determined by MTT assay, the cell apoptotic rate were detected by AnnexinV-FITC flow cytometry, and the cell morphological changes were observed under inverted phase contrast microscope. The expression of TNF-α and IL-1β mRNA were determined by qRT-PCR.

RESULTS: Compared with those in the control group, the number of adherent cells was significantly decreased, neurite structures were reduced, and the cell viability was decreased, while the apoptotic rate and expressions of TNF-α and IL-1β mRNA were increased in AD group (P<0.05). Compared with that in AD group, the number of adherent cells was increased in NBP group and the cell morphology was similar to the normal control cells. The cell viability of N2a cells was increased in NBP group with decreased apoptotic rate and expression of TNF-αand IL-1β mRNA (P<0.05).

CONCLUSION: Butylphthalide can protect against AD in the cell model induced by Aβ25-35 possibly by inhibiting the expression of inflammatory cytokines.

References

  1. Biochem Soc Trans. 2011 Aug;39(4):886-90 - PubMed
  2. Brain Res. 2015 Jan 30;1596:136-45 - PubMed
  3. J Neurosci. 2010 Jun 16;30(24):8180-9 - PubMed
  4. Biochim Biophys Acta. 2014 Nov;1842(11):2276-85 - PubMed
  5. CNS Neurosci Ther. 2016 Dec;22(12):979-987 - PubMed
  6. Nan Fang Yi Ke Da Xue Xue Bao. 2009 Aug;29(8):1592-5 - PubMed
  7. J Asian Nat Prod Res. 2014;16(8):854-64 - PubMed
  8. Neurobiol Dis. 2017 Jun;102:81-95 - PubMed
  9. Neurotherapeutics. 2015 Jan;12(1):81-93 - PubMed
  10. Mol Immunol. 2007 Feb;44(5):999-1010 - PubMed
  11. J Alzheimers Dis. 2016 Nov 1;55(1):101-113 - PubMed
  12. J Neurochem. 2016 Feb;136(3):457-74 - PubMed
  13. Neuropsychopharmacology. 2014 Jan;39(2):401-14 - PubMed
  14. J Cent Nerv Syst Dis. 2017 Jul 28;9:1179573517722512 - PubMed
  15. Am J Pathol. 2008 Dec;173(6):1768-82 - PubMed
  16. Int J Clin Exp Med. 2014 Jul 15;7(7):1706-13 - PubMed
  17. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Sep;30(9):2104-7 - PubMed
  18. Neurobiol Dis. 2014 Feb;62:273-85 - PubMed
  19. Cell Physiol Biochem. 2013;32(1):235-42 - PubMed
  20. Neurobiol Aging. 2013 Aug;34(8):2064-70 - PubMed
  21. PLoS One. 2014 Oct 14;9(10):e110024 - PubMed

Publication Types